Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Parkinson's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 100 articles: HTML format

Single Articles

April 2025
1. XUE G, Wang G, Shi Q, Wang H, et al
   Exploring the dynamic pathogenesis of Parkinson's disease by case-control and longitudinal blood transcriptome analyses.
   Neurobiol Dis. 2025;209:106891.
   PubMed     Abstract available
   
   
   
2. WEN S, Li Y, Xiang W, Shen F, et al
   A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes.
   Neurobiol Dis. 2025;209:106899.
   PubMed     Abstract available
   
   
   March 2025
3. MINGO YB, Escobar Galvis ML, Henderson MX
   alpha-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease.
   Neurobiol Dis. 2025;209:106889.
   PubMed     Abstract available
   
   
   
4. YUAN YT, Hong WP, Tan CH, Yu RL, et al
   Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease.
   Neurobiol Dis. 2025;208:106887.
   PubMed     Abstract available
   
   
   
5. BUONOCORE A, Cafaro C, De Luca C, Vermiglio G, et al
   Lack of pre-movement facilitation as neurophysiological hallmark of fatigue in patients with Parkinson's disease: A single pulse TMS study.
   Neurobiol Dis. 2025;208:106878.
   PubMed     Abstract available
   
   
   
6. LINAN VS, Rioux V, Peralta M 3rd, Dupre N, et al
   Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers.
   Neurobiol Dis. 2025 Mar 14:106872. doi: 10.1016/j.nbd.2025.106872.
   PubMed     Abstract available
   
   
   
7. SUN H, Gan C, Cao X, Yuan Y, et al
   Microstructural and functional abnormalities of the locus coeruleus in freezing of gait in Parkinson's disease.
   Neurobiol Dis. 2025 Mar 9:106868. doi: 10.1016/j.nbd.2025.106868.
   PubMed     Abstract available
   
   
   
8. WANG B, Gannon M, Pattanayak R, Scholz K, et al
   14-3-3theta phosphorylation exacerbates alpha-synuclein aggregation and toxicity.
   Neurobiol Dis. 2025;206:106801.
   PubMed     Abstract available
   
   
   February 2025
9. WICHMANN T, Nelson A, Torres ERS, Svenningsson P, et al
   Leveraging animal models to understand non-motor symptoms of Parkinson's disease.
   Neurobiol Dis. 2025 Feb 27:106848. doi: 10.1016/j.nbd.2025.106848.
   PubMed     Abstract available
   
   
   
10. FREDLUND F, Fryklund C, Trujeque-Ramos O, Staley HA, et al
    Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-alpha-Syn?+?PFFs-induced rat model for Parkinson's disease.
    Neurobiol Dis. 2025 Feb 13:106841. doi: 10.1016/j.nbd.2025.106841.
    PubMed     Abstract available
    
    
    
11. DIAO Y, Yin Z, Zhao B, Xu Y, et al
    Abnormal neuronal activity in the subthalamic nucleus contributes to dysarthria in patients with Parkinson's disease.
    Neurobiol Dis. 2025 Feb 3:106830. doi: 10.1016/j.nbd.2025.106830.
    PubMed     Abstract available
    
    
    
12. HARTKE AS, Schreiber CS, Lau K, Wiesweg I, et al
    Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins.
    Neurobiol Dis. 2025;205:106773.
    PubMed     Abstract available
    
    
    January 2025
13. GUO T, Zhou C, Wen J, Wu J, et al
    Aberrant functional connectome gradient and its neurotransmitter basis in Parkinson's disease.
    Neurobiol Dis. 2025;206:106821.
    PubMed     Abstract available
    
    
    
14. DEL PERCIO C, Lizio R, Lopez S, Noce G, et al
    Resting-state electroencephalographic rhythms depend on sex in patients with dementia due to Parkinson's and Lewy Body diseases: An exploratory study.
    Neurobiol Dis. 2025;206:106807.
    PubMed     Abstract available
    
    
    
15. BOLEN ML, Gomes BN, Gill B, Menees KB, et al
    Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs.
    Neurobiol Dis. 2025 Jan 11:106794. doi: 10.1016/j.nbd.2025.106794.
    PubMed     Abstract available
    
    
    December 2024
16. HUANG CW, Tsai HY, Lin YH, Lin WW, et al
    Striatal-cortical dysconnectivity underlies somatosensory deficits in Parkinson's disease: Insights from rhythmic auditory-motor training.
    Neurobiol Dis. 2024 Dec 22:106778. doi: 10.1016/j.nbd.2024.106778.
    PubMed     Abstract available
    
    
    October 2024
17. LAI MS, Sorensen MH, Lee K, Chu JM, et al
    3D mapping of direct VTA-CA2 circuit with potential involvement in Parkinson's disease degeneration.
    Neurobiol Dis. 2024;202:106723.
    PubMed     Abstract available
    
    
    
18. CARRILLO F, Palomba NP, Ghirimoldi M, Dido C, et al
    Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.
    Neurobiol Dis. 2024 Oct 18:106698. doi: 10.1016/j.nbd.2024.106698.
    PubMed     Abstract available
    
    
    
19. CAO C, Litvak V, Zhan S, Liu W, et al
    Low-beta versus high-beta band cortico-subcortical coherence in movement inhibition and expectation.
    Neurobiol Dis. 2024;201:106689.
    PubMed     Abstract available
    
    
    
20. MASSARI CM, Dues DJ, Bergsma A, Sipple K, et al
    Neuropathology in an alpha-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.
    Neurobiol Dis. 2024;202:106701.
    PubMed     Abstract available
    
    
    
21. MENDONCA MD, Ferreira P, Barbosa R, da Silva JA, et al
    Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor.
    Neurobiol Dis. 2024;201:106691.
    PubMed     Abstract available
    
    
    
22. CHEN B, Zhou H, Liu X, Yang W, et al
    Correlations of gray matter volume with peripheral cytokines in Parkinson's disease.
    Neurobiol Dis. 2024 Oct 3:106693. doi: 10.1016/j.nbd.2024.106693.
    PubMed     Abstract available
    
    
    September 2024
23. LIU J, Ji Z, He Q, Chen H, et al
    Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
    Neurobiol Dis. 2024;201:106683.
    PubMed     Abstract available
    
    
    
24. SHEN B, Yao Q, Li W, Dong S, et al
    Dynamic cerebellar and sensorimotor network compensation in tremor-dominated Parkinson's disease.
    Neurobiol Dis. 2024;201:106659.
    PubMed     Abstract available
    
    
    
25. SERMON JJ, Wiest C, Tan H, Denison T, et al
    Evoked resonant neural activity long-term dynamics can be reproduced by a computational model with vesicle depletion.
    Neurobiol Dis. 2024;199:106565.
    PubMed     Abstract available
    
    
    August 2024
26. PARK DG, Kang W, Shin IJ, Chalita M, et al
    Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease.
    Neurobiol Dis. 2024;201:106655.
    PubMed     Abstract available
    
    
    
27. GRENNAN I, Mallet N, Magill PJ, Cagnan H, et al
    Beta bursts in the parkinsonian cortico-basal ganglia network form spatially discrete ensembles.
    Neurobiol Dis. 2024 Aug 27:106652. doi: 10.1016/j.nbd.2024.106652.
    PubMed     Abstract available
    
    
    
28. STETZIK L, Mercado G, Steiner JA, Lindquist A, et al
    Heterozygous loss of Engrailed-1 and alpha-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.
    Neurobiol Dis. 2024 Aug 24:106647. doi: 10.1016/j.nbd.2024.106647.
    PubMed     Abstract available
    
    
    
29. LI B, Dettmer U
    Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.
    Neurobiol Dis. 2024 Aug 22:106646. doi: 10.1016/j.nbd.2024.106646.
    PubMed     Abstract available
    
    
    
30. MASSACCI G, Venafra V, Zwiebel M, Wahle M, et al
    Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells.
    Neurobiol Dis. 2024;200:106622.
    PubMed     Abstract available
    
    
    July 2024
31. CAMPAGNOLO M, Weis L, Sandre M, Tushevski A, et al
    Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort.
    Neurobiol Dis. 2024;200:106609.
    PubMed     Abstract available
    
    
    
32. ADOM MA, Hahn WN, McCaffery TD, Moors TE, et al
    Reducing the lipase LIPE in mutant alpha-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism.
    Neurobiol Dis. 2024;199:106593.
    PubMed     Abstract available
    
    
    
33. FASANO A, Mure H, Oyama G, Murase N, et al
    Subthalamic nucleus local field potential stability in patients with Parkinson's disease.
    Neurobiol Dis. 2024;199:106589.
    PubMed     Abstract available
    
    
    June 2024
34. MESAROSOVA L, Scheper M, Iyer A, Anink JJ, et al
    miR-193b-3p/ PGC-1alpha pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 29:106587. doi: 10.1016/j.nbd.2024.106587.
    PubMed     Abstract available
    
    
    
35. LI X, Pang H, Bu S, Zhao M, et al
    Stage-dependent differential impact of network communication on cognitive function across the continuum of cognitive decline in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 24:106578. doi: 10.1016/j.nbd.2024.106578.
    PubMed     Abstract available
    
    
    
36. TEZUKA T, Ishiguro M, Taniguchi D, Osogaguchi E, et al
    Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.
    Neurobiol Dis. 2024 Jun 18:106571. doi: 10.1016/j.nbd.2024.106571.
    PubMed     Abstract available
    
    
    
37. MASATO A, Bubacco L
    The alphaSynuclein half-life conundrum.
    Neurobiol Dis. 2024;196:106524.
    PubMed     Abstract available
    
    
    
38. GAO AYL, Montagna DR, Hirst WD, Temkin PA, et al
    RIT2 regulates autophagy lysosomal pathway induction and protects against alpha-synuclein pathology in a cellular model of Parkinson's disease.
    Neurobiol Dis. 2024;199:106568.
    PubMed     Abstract available
    
    
    
39. BAARBE J, Brown MJN, Saha U, Tran S, et al
    Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson's disease: an EEG source localization study.
    Neurobiol Dis. 2024 Jun 7:106557. doi: 10.1016/j.nbd.2024.106557.
    PubMed     Abstract available
    
    
    
40. GAN C, Cao X, Sun H, Ye S, et al
    Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Neurobiol Dis. 2024;198:106560.
    PubMed     Abstract available
    
    
    
41. LEAVITT D, Alanazi FI, Al-Ozzi TM, Cohn M, et al
    Auditory oddball responses in the human subthalamic nucleus and substantia nigra pars reticulata.
    Neurobiol Dis. 2024;195:106490.
    PubMed     Abstract available
    
    
    
42. YAN S, Lu J, Duan B, Zhu H, et al
    Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps.
    Neurobiol Dis. 2024;198:106549.
    PubMed     Abstract available
    
    
    May 2024
43. CASANOVA F, Tian Q, Williamson DS, Qian Y, et al
    MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Neurobiol Dis. 2024 May 22:106539. doi: 10.1016/j.nbd.2024.106539.
    PubMed     Abstract available
    
    
    
44. GULBERTI A, Schneider TR, Galindo-Leon EE, Heise M, et al
    Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106529. doi: 10.1016/j.nbd.2024.106529.
    PubMed     Abstract available
    
    
    
45. SHI D, Wu S, Zhuang C, Mao Y, et al
    Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106527. doi: 10.1016/j.nbd.2024.106527.
    PubMed     Abstract available
    
    
    
46. ILIEVA NM, Hoffman EK, Ghalib MA, Greenamyre JT, et al
    LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
    Neurobiol Dis. 2024 May 3:106522. doi: 10.1016/j.nbd.2024.106522.
    PubMed     Abstract available
    
    
    
47. HEMBACH S, Schmidt S, Orschmann T, Burtscher I, et al
    Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation.
    Neurobiol Dis. 2024;194:106474.
    PubMed     Abstract available
    
    
    April 2024
48. GUO X, He S, Geng X, Yao P, et al
    Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 27:106519. doi: 10.1016/j.nbd.2024.106519.
    PubMed     Abstract available
    
    
    
49. RURAK BK, Tan J, Rodrigues JP, Power BD, et al
    Cortico-cortical connectivity is influenced by levodopa in tremor-dominant Parkinson's disease.
    Neurobiol Dis. 2024;196:106518.
    PubMed     Abstract available
    
    
    
50. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
    RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
    PubMed     Abstract available
    
    
    
51. BUOSO C, Seifert M, Lang M, Griffith CM, et al
    Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
    PubMed     Abstract available
    
    
    
52. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed     Abstract available
    
    
    
53. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    PubMed     Abstract available
    
    
    March 2024
54. IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
    Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
    Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
    PubMed     Abstract available
    
    
    
55. ZHOU C, You J, Guan X, Guo T, et al
    Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
    Neurobiol Dis. 2024 Mar 11:106472. doi: 10.1016/j.nbd.2024.106472.
    PubMed     Abstract available
    
    
    February 2024
56. HUANG YT, Chen YW, Lin TY, Chen JC, et al
    Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
    Neurobiol Dis. 2024;193:106452.
    PubMed     Abstract available
    
    
    
57. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
    Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Neurobiol Dis. 2024;191:106411.
    PubMed     Abstract available
    
    
    January 2024
58. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
    Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
    Neurobiol Dis. 2024;192:106413.
    PubMed     Abstract available
    
    
    
59. WU C, Wu H, Zhou C, Guan X, et al
    Neurovascular coupling alteration in drug-naive Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects.
    Neurobiol Dis. 2024 Jan 8:106406. doi: 10.1016/j.nbd.2024.106406.
    PubMed     Abstract available
    
    
    
60. SALIN P, Melon C, Chassain C, Gubellini P, et al
    Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism.
    Neurobiol Dis. 2024;191:106398.
    PubMed     Abstract available
    
    
    December 2023
61. TRAN S, Heida TC, Heijs JJA, Al-Ozzi T, et al
    Subthalamic and pallidal neurons are modulated during externally cued movements in Parkinson's disease.
    Neurobiol Dis. 2023 Dec 20:106384. doi: 10.1016/j.nbd.2023.106384.
    PubMed     Abstract available
    
    
    
62. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    PubMed     Abstract available
    
    
    
63. DI LAZZARO G, Picca A, Boldrini S, Bove F, et al
    Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
    Neurobiol Dis. 2023 Dec 5:106371. doi: 10.1016/j.nbd.2023.106371.
    PubMed     Abstract available
    
    
    November 2023
64. TSHILENGE KT, Bons J, Aguirre CG, Geronimo-Olvera C, et al
    Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Neurobiol Dis. 2023 Nov 30:106367. doi: 10.1016/j.nbd.2023.106367.
    PubMed     Abstract available
    
    
    
65. TOFFOLI M, Chohan H, Mullin S, Jesuthasan A, et al
    Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
    Neurobiol Dis. 2023 Nov 3:106343. doi: 10.1016/j.nbd.2023.106343.
    PubMed     Abstract available
    
    
    
66. HARVEY J, Pishva E, Chouliaras L, Lunnon K, et al
    Elucidating distinct molecular signatures of Lewy body dementias.
    Neurobiol Dis. 2023;188:106337.
    PubMed     Abstract available
    
    
    
67. TUBERT C, Zampese E, Pancani T, Tkatch T, et al
    Feed-forward metabotropic signaling by Cav1 Ca(2+) channels supports pacemaking in pedunculopontine cholinergic neurons.
    Neurobiol Dis. 2023;188:106328.
    PubMed     Abstract available
    
    
    
68. DUES DJ, Ma Y, Nguyen APT, Offerman AV, et al
    Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2.
    Neurobiol Dis. 2023;188:106338.
    PubMed     Abstract available
    
    
    October 2023
69. RIVAS-SANTISTEBAN R, Rico A, Munoz A, Rodriguez AI, et al
    Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.
    Neurobiol Dis. 2023 Oct 31:106341. doi: 10.1016/j.nbd.2023.106341.
    PubMed     Abstract available
    
    
    
70. CHEN L, Sun J, Gao L, Wang J, et al
    Dysconnectivity of the parafascicular nucleus in Parkinson's disease: A dynamic causal modeling analysis.
    Neurobiol Dis. 2023;188:106335.
    PubMed     Abstract available
    
    
    
71. LI T, Liu T, Zhang J, Ma Y, et al
    Neurovascular coupling dysfunction of visual network organization in Parkinson's disease.
    Neurobiol Dis. 2023;188:106323.
    PubMed     Abstract available
    
    
    
72. MAPLE-GRODEM J, Ushakova A, Pedersen KF, Tysnes OB, et al
    Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach.
    Neurobiol Dis. 2023;186:106281.
    PubMed     Abstract available
    
    
    
73. SCHAFFNER SL, Wassouf Z, Hentrich T, Nuesch-Germano M, et al
    Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
    Neurobiol Dis. 2023;186:106274.
    PubMed     Abstract available
    
    
    September 2023
74. DE FABREGUES O, Selles M, Ramos-Vicente D, Roch G, et al
    Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?
    Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
    PubMed     Abstract available
    
    
    
75. TRINH D, Israwi AR, Brar H, Villafuerte JEA, et al
    Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
    Neurobiol Dis. 2023 Sep 11:106287. doi: 10.1016/j.nbd.2023.106287.
    PubMed     Abstract available
    
    
    August 2023
76. GRONLIER E, Volle J, Coizet V, Paccard A, et al
    Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
    Neurobiol Dis. 2023 Aug 19:106266. doi: 10.1016/j.nbd.2023.106266.
    PubMed     Abstract available
    
    
    
77. GAN C, Ji M, Sun H, Cao X, et al
    Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease.
    Neurobiol Dis. 2023;185:106265.
    PubMed     Abstract available
    
    
    
78. REN J, Yan L, Zhou H, Pan C, et al
    Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
    Neurobiol Dis. 2023 Aug 7:106254. doi: 10.1016/j.nbd.2023.106254.
    PubMed     Abstract available
    
    
    
79. DUMONT M, Agostinis A, Singh K, Swan E, et al
    Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
    Neurobiol Dis. 2023;184:106214.
    PubMed     Abstract available
    
    
    
80. BHATIA TN, Jamenis AS, Abbas M, Clark RN, et al
    A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes.
    Neurobiol Dis. 2023;184:106196.
    PubMed     Abstract available
    
    
    July 2023
81. CROCKETT RA, Wilkins KB, Aditham S, Bronte-Stewart HM, et al
    No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Neurobiol Dis. 2023 Jul 29:106243. doi: 10.1016/j.nbd.2023.106243.
    PubMed     Abstract available
    
    
    
82. URSO D, Batzu L, Logroscino G, Chaudhuri KR, et al
    Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease.
    Neurobiol Dis. 2023 Jul 25:106237. doi: 10.1016/j.nbd.2023.106237.
    PubMed     Abstract available
    
    
    
83. AVANTAGGIATO F, Farokhniaee A, Bandini A, Palmisano C, et al
    Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Neurobiol Dis. 2023 Jul 25:106239. doi: 10.1016/j.nbd.2023.106239.
    PubMed     Abstract available
    
    
    
84. WANG Y, Xia Y, Kou L, Yin S, et al
    Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
    Neurobiol Dis. 2023 Jul 9:106224. doi: 10.1016/j.nbd.2023.106224.
    PubMed     Abstract available
    
    
    
85. LEGAZ A, Prado P, Moguilner S, Baez S, et al
    Social and non-social working memory in neurodegeneration.
    Neurobiol Dis. 2023;183:106171.
    PubMed     Abstract available
    
    
    June 2023
86. WU H, Wu C, Qin J, Zhou C, et al
    Functional connectome predicting individual gait function and its relationship with molecular architecture in Parkinson's disease.
    Neurobiol Dis. 2023;184:106216.
    PubMed     Abstract available
    
    
    
87. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
    Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
    PubMed     Abstract available
    
    
    
88. BATZU L, Urso D, Grothe MJ, Vereb D, et al
    Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
    Neurobiol Dis. 2023 Jun 5:106182. doi: 10.1016/j.nbd.2023.106182.
    PubMed     Abstract available
    
    
    
89. ZHONG M, Wang Y, Lin G, Liao FF, et al
    Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines.
    Neurobiol Dis. 2023;181:106096.
    PubMed     Abstract available
    
    
    May 2023
90. LUCHETTI S, Liere P, Pianos A, Verwer RWH, et al
    Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.
    Neurobiol Dis. 2023 May 29:106169. doi: 10.1016/j.nbd.2023.106169.
    PubMed     Abstract available
    
    
    
91. YIN Z, Jiang Y, Merk T, Neumann WJ, et al
    Pallidal activities during sleep and sleep decoding in dystonia, Huntington's, and Parkinson's disease.
    Neurobiol Dis. 2023 May 3:106143. doi: 10.1016/j.nbd.2023.106143.
    PubMed     Abstract available
    
    
    
92. FAYARD A, Fenyi A, Lavisse S, Dovero S, et al
    Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.
    Neurobiol Dis. 2023;180:106086.
    PubMed     Abstract available
    
    
    
93. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
    The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
    Neurobiol Dis. 2023;180:106082.
    PubMed     Abstract available
    
    
    April 2023
94. GUERRA A, Colella D, Cannavacciuolo A, Giangrosso M, et al
    Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
    Neurobiol Dis. 2023;182:106137.
    PubMed     Abstract available
    
    
    
95. HAYLEY S, Vahid-Ansari F, Sun H, Albert PR, et al
    Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models.
    Neurobiol Dis. 2023 Apr 8:106115. doi: 10.1016/j.nbd.2023.106115.
    PubMed     Abstract available
    
    
    
96. SASIKUMAR S, Sorrento G, Lang AE, Strafella AP, et al
    Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease.
    Neurobiol Dis. 2023 Apr 3:106109. doi: 10.1016/j.nbd.2023.106109.
    PubMed     Abstract available
    
    
    March 2023
97. CAULFIELD ME, Vander Werp MJ, Stancati JA, Collier TJ, et al
    Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age.
    Neurobiol Dis. 2023 Mar 29:106111. doi: 10.1016/j.nbd.2023.106111.
    PubMed     Abstract available
    
    
    
98. HUANG Q, Chen C, Chen W, Cai C, et al
    Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
    Neurobiol Dis. 2023;180:106105.
    PubMed     Abstract available
    
    
    
99. TAN S, Zhou C, Wen J, Duanmu X, et al
    Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.
    Neurobiol Dis. 2023;180:106084.
    PubMed     Abstract available
    
    
    
100. PORRINI V, Pilotto A, Vezzoli M, Lanzillotta A, et al
     NF-kappaB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
     Neurobiol Dis. 2023 Mar 7:106067. doi: 10.1016/j.nbd.2023.106067.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.